HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (2) Citing Articles via Google Scholar Google Scholar Articles by Koska, J. Articles by Bunt, J. C. Search for Related Content PubMed PubMed Citation Articles by Koska, J. Articles by Bunt, J. C.

The effect of insulin on net lipid oxidation predicts worsening of insulin resistance and development of type 2 diabetes mellitus

Obesity and Diabetes Clinical Research Section, National Institute of Diabetes and Digestive and Kidney Diseases/National Institutes of Health/Department of Health and Human Services, Phoenix, Arizona

Submitted 5 December 2006 ; accepted in final form 29 March 2007

Suppression of lipid oxidation (L_ox) by insulin is impaired in obesity and type 2 diabetes mellitus (T2DM). Here we tested whether high L_ox represents a primary or acquired characteristic in the pathogenesis of T2DM. Hood-indirect calorimetry was performed under postabsorptive conditions and during a two-step hyperinsulinemic euglycemic clamp (insulin infusion rates in mU·m^–2·min^–1: 40 low and 400 high) in 465 Pima Indians: 317 with normal glucose tolerance (NGT), 117 with impaired glucose tolerance (IGT), and 31 with T2DM. The predictive effect of net lipid oxidation (L_ox) on development of T2DM was assessed in 296 subjects (51 of whom developed T2DM), whereas the predictive effect of L_ox on followup changes in insulin-mediated glucose disposal (M) and acute insulin response (AIR) was studied in 190 subjects with NGT at baseline. Cross-sectionally, after adjustment for age, sex, body fat (BF), and M low, L_ox low was increased in T2DM compared with NGT and IGT subjects (P < 0.05). Prospectively, after adjustment for followup duration, age, sex, BF, M, and AIR, increased clamp L_ox predicted T2DM [hazard rate ratios (95% CI): L_ox low, 1.5 (1.1, 2.0), P < 0.01; L_ox high, 1.3 (1.0, 1.8), P = 0.05]. High L_ox low at baseline was also associated with subsequent worsening of M low (P = 0.04). These data indicate that the inability of insulin to suppress L_ox may represent an early risk marker for insulin resistance and T2DM that is independent of adiposity, acute insulin secretion, and insulin action on glucose uptake.

diabetes mellitus; euglycemic clamp; indirect calorimetry

This article has been cited by other articles:

				A. Gastaldelli, A. Casolaro, D. Ciociaro, S. Frascerra, M. Nannipieri, E. Buzzigoli, and E. Ferrannini Decreased whole body lipolysis as a mechanism of the lipid-lowering effect of pioglitazone in type 2 diabetic patients Am J Physiol Endocrinol Metab, July 1, 2009; 297(1): E225 - E230. [Abstract] [Full Text] [PDF]

				J. E. Galgani, L. K. Heilbronn, K. Azuma, D. E. Kelley, J. B. Albu, X. Pi-Sunyer, S. R. Smith, E. Ravussin, and and the Look AHEAD Adipose Research Group Metabolic Flexibility in Response to Glucose Is Not Impaired in People With Type 2 Diabetes After Controlling for Glucose Disposal Rate Diabetes, April 1, 2008; 57(4): 841 - 845. [Abstract] [Full Text] [PDF]